Ayrshire Capital Management LLC purchased a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the third quarter, HoldingsChannel.com reports. The institutional investor purchased 5,936 shares of the company’s stock, valued at approximately $3,188,000. Eli Lilly and Company accounts for 2.1% of Ayrshire Capital Management LLC’s investment portfolio, making the […]